Extremely high serum level of IgE during immunosuppressive therapy: Paradoxical effect of cyclosporine A and tacrolimus

International Archives of Allergy and Immunology

Volumn 112, Issue 4, 1997, Pages 422-424

  Kawamura, Nobuaki ^a   Furuta, Hirofumi ^a   Tame, Atsushi ^a   Kobayashi, Ichiro ^a   Ariga, Tadashi ^a   Okano, Motohiko ^a   Sakiyama, Yukio ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Autoimmune disease; Cyclosporine A; FK506; IgE; Interleukin 4

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G4; TACROLIMUS;

ARTICLE; AUTOIMMUNITY; CASE REPORT; DRUG THERAPY; ENTEROPATHY; EOSINOPHIL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 0030949826     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237491     Document Type: Article

References (12)

1. Prudhomme GJ, Vatier LE: Cyclosporinc, tolerance, and autoimmunity, Clin Immunol Im-munopathol 1993;66:185-192.
2. Satakc N, Nakanishi M, Okano M, Tomizawa K, Ishizaka A, Kojima K, Onodcra M, Ariga T, Satakc A, Sakiyama Y, Ishikawa N, Matsumoto S: A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and poly-endocrinopathy, Eur J Pcdiatr 1993; 152:313-315.
3. Kobayashi I, Nakanishi M, Okano M, Sakiyama Y, Matsumoto S: Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy, Eur J Pcdiatr 1995;154:594-595.
4. Ehlers S, Smith KA: Differentiation of T cell lymphokine gene expression: The in vitro acquisition of T cell memory, J Exp Med 1991; 173:25-36.
5. Chen SS, Li Q, Pcarlman E, Chen WH: Dual mechanism of potentiation of murine antigen-specific IgE production by cyclospolin A in vitro, J Immunol 1992;149:762-767.
6. Siekierka JJ, Sigal Nil: I-K506 and cyclosporin A: Immunosuppressive mechanism of action and beyond, Curr Opin Immunol 1992:4:548-552.
7. Bundick RV, Craggs RI, Holncss E: The effect of cyclosporin A, FK506. and rapamycin on the murine chronic graft-versus-host response: An in vivo model ofTh2-iike activity, Clin Exp Immunol 1995;99:467-472.
8. Zheng XX, Strom TB, Steele AW: Quantitative comparison of rapamycin and cyclospoline effects on cytokine gene expression studied by reverse transcriptase-competitive polymerase chain reaction, Transplantation I994;58:87-92.
9. Wang SC, Zecvi A, Jordan ML, Simmons RL, Twcardy DJ: FK506. rapamycin, and cyclospoline: Effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line, Transplant Proc 1991;23: 2920-2922.
10. Bradding P, Feather III, Howarth PH, Mueller R, Roberts JA, Britten K, Bcws JPA, Hunt TC, Okayama Y, Hcusser CH, Bullock GR, Chrch MK, Holgate ST: Interleukin 4 is localized to and released by human mast cells, J Exp Med 1992;176:1381-1386.
11. Brunner T, Hcusser CH, Dahinden CA: Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation, J Exp Med 1993;177:605-611.
12. Williams ME, Kullberg MC, Barbicri S, Caspar P, Berzofsky JA, Seder RA, Sher A: Fee receptor-positive cells are a major source of antigen-induced interleukin-4 in spleens of mice infected with Schistosoma mansoni, Eur J Immunol 1993;23:1910-1916.